Omentin-1 Levels and Outcomes in Incident Peritoneal Dialysis PatientsPlain-Language summary
Win Hlaing Than, Gordon Chun-Kau Chan, Bonnie Ching-Ha Kwan and 9 more
Kidney Medicine · 2023
doi:10.1016/j.xkme.2023.100598 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Rationale & Objective Omentin-1 is an adipokine with anti-inflammatory and cardioprotective properties. The objective of this study was to determine the prognostic role of plasma omentin-1 levels in incident peritoneal dialysis (PD) patients. Study Design Retrospective analysis of prospective cohort. Setting & Participants 152 incident PD patients. Predictors Plasma omentin-1 level, adipose tissue omentin-1 messenger RNA (mRNA) expression. Outcomes Patient survival, technique survival, hospital admission, and duration of stay. Analytical Approach Time-to-event survival analyses; linear regression for hospitalization. Results The mean age was 58.4±11.7 years; 102 were men, and 92 had diabetes. There was no significant correlation between plasma omentin-1 level and its adipose tissue mRNA expression. A higher plasma omentin-1 level quartile was not associated with patient survival ( P =0.92) or technique survival ( P =0.83) but had a modest correlation with a lower number of hospital admissions ( P =0.07) and shorter duration of hospital stay ( P =0.04). In adjusted models using multivariable linear regression, a higher plasma omentin-1 level quartile remained significantly associated with fewer hospital admissions (β, -0.13; 95% CI, -0.26 to -0.002; P =0.05) and shorter hospitalization duration (β, -0.20; 95% CI, -0.38 to -0.02; P =0.03). Limitations Observational study with baseline measures only. Conclusions Plasma omentin-1 level was not associated with patient survival, technique survival, or peritonitis, but higher plasma omentin-1 levels were associated with fewer hospital admissions and shorter duration of hospitalization among incident PD patients.
Abstract licence: CC BY-NC-ND
References45
- 37.
39 more references, whose wording the paper’s licence keeps private.
All 45 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.